Product Overview

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Intrauterine

Duration Type: Long-acting

Description: An levonorgestrel IUS developed by SIPPR.

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Early Development

Project Stage: Pre-clinical

Began discovery in: 2006

Status Details:
  • The SIPPR product was compared to Mirena in rabbits and found to produce similar LNG plasma concentrations and similar histology in rabbit reproductive organs. Clinical testing in humans is planned.

Download Product Report